{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:12:27Z","timestamp":1786374747606,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.2459\/jcm.0b013e32833186a4","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T08:52:49Z","timestamp":1283331169000},"page":"199-206","source":"Crossref","is-referenced-by-count":4,"title":["The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study"],"prefix":"10.2459","volume":"11","author":[{"given":"Leonardo","family":"Bolognese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Falsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Grotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Limbruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Liistro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Picchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pierli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210207","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"Am J Med"},{"key":"R2-12-20210207","first-page":"1343","article-title":"The renal patient with coronary artery disease: current concepts and dilemmas","volume":"44","author":"Gupta","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R3-12-20210207","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2004.03.008","article-title":"Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification","volume":"93","author":"Bartholomew","year":"2004","journal-title":"Am J Cardiol"},{"key":"R4-12-20210207","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R5-12-20210207","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","author":"Rihal","year":"2002","journal-title":"Circulation"},{"key":"R6-12-20210207","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ccd.21565","article-title":"The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography","volume":"71","author":"Weisbord","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"R7-12-20210207","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1148\/radiology.203.3.9169676","article-title":"Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration","volume":"203","author":"Lasser","year":"1997","journal-title":"Radiology"},{"key":"R8-12-20210207","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM198901193200303","article-title":"Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study","volume":"320","author":"Parfrey","year":"1989","journal-title":"N Engl J Med"},{"key":"R9-12-20210207","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archinte.1990.00390180067011","article-title":"Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study","volume":"150","author":"Rich","year":"1990","journal-title":"Arch Intern Med"},{"key":"R10-12-20210207","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ki.5000367","article-title":"Contrast medium-induced nephropathy: the pathophysiology","volume":"69","author":"Persson","year":"2006","journal-title":"Kidney Int"},{"key":"R11-12-20210207","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","article-title":"Pathophysiology of contrast medium-induced nephropathy","volume":"68","author":"Persson","year":"2005","journal-title":"Kidney Int"},{"key":"R12-12-20210207","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2214\/ajr.141.5.1027","article-title":"Predicting angiography-induced acute renal function impairment: clinical risk model","volume":"141","author":"Cochran","year":"1983","journal-title":"AJR Am J Roentgenol"},{"issue":"Suppl 5","key":"R13-12-20210207","first-page":"S3","article-title":"Epidemiology of contrast-induced nephropathy","volume":"4","author":"McCullough","year":"2003","journal-title":"Rev Cardiovasc Med"},{"key":"R15-12-20210207","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2004.07.043","article-title":"Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction","volume":"44","author":"Marenzi","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R16-12-20210207","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1056\/NEJMoa054209","article-title":"N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty","volume":"354","author":"Marenzi","year":"2006","journal-title":"N Engl J Med"},{"key":"R17-12-20210207","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jacc.2006.11.034","article-title":"The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study","volume":"49","author":"Recio-Mayoral","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R19-12-20210207","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.188.1.8511292","article-title":"Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media","volume":"188","author":"Barrett","year":"1993","journal-title":"Radiology"},{"key":"R20-12-20210207","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","article-title":"Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study","volume":"47","author":"Rudnick","year":"1995","journal-title":"Kidney Int"},{"key":"R21-12-20210207","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"key":"R22-12-20210207","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1259\/bjr.72.859.10624328","article-title":"Comparison of iodixanol and iohexol in renal impairment","volume":"72","author":"Chalmers","year":"1999","journal-title":"Br J Radiol"},{"key":"R23-12-20210207","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jacc.2006.06.047","article-title":"Renal toxicity evaluation and comparison between Visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study \u2013 a randomized controlled trial","volume":"48","author":"Jo","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R24-12-20210207","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/j.1523-1755.2005.00683.x","article-title":"Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine","volume":"68","author":"Briguori","year":"2005","journal-title":"Kidney Int"},{"key":"R25-12-20210207","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2008.05.023","article-title":"Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography\/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial","volume":"156","author":"Rudnick","year":"2008","journal-title":"Am Heart J"},{"key":"R26-12-20210207","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/RLI.0b013e3181514413","article-title":"A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography","volume":"42","author":"Sahani","year":"2007","journal-title":"Invest Radiol"},{"key":"R27-12-20210207","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/RLI.0b013e31815f3172","article-title":"The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography","volume":"43","author":"Thomsen","year":"2008","journal-title":"Invest Radiol"},{"key":"R28-12-20210207","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2214\/AJR.07.3370","article-title":"The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or iso-osmolar contrast agent exposure","volume":"191","author":"Kuhn","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"R29-12-20210207","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s003300050356","article-title":"Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial","volume":"8","author":"Carraro","year":"1998","journal-title":"Eur Radiol"},{"key":"R30-12-20210207","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.rli.0000242807.01818.24","article-title":"Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol","volume":"41","author":"Barrett","year":"2006","journal-title":"Invest Radiol"},{"key":"R31-12-20210207","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1148\/radiol.2481071484","article-title":"Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function","volume":"248","author":"Nguyen","year":"2008","journal-title":"Radiology"},{"key":"R32-12-20210207","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1161\/CIRCULATIONAHA.106.671644","article-title":"Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease","volume":"115","author":"Solomon","year":"2007","journal-title":"Circulation"},{"key":"R34-12-20210207","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/02841850801901791","article-title":"Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study","volume":"49","author":"From","year":"2008","journal-title":"Acta Radiol"},{"key":"R35-12-20210207","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1148\/radiol.2501080833","article-title":"Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials","volume":"250","author":"Heinrich","year":"2009","journal-title":"Radiology"},{"key":"R36-12-20210207","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1378\/chest.116.4.1039","article-title":"Effect of contrast media on coronary vascular resistance: contrast-induced coronary vasodilation","volume":"116","author":"Baile","year":"1999","journal-title":"Chest"},{"key":"R37-12-20210207","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ccd.1810230220","article-title":"Effects of intracoronary administration of contrast media on coronary hemodynamics in a canine post ischemic reperfusion model","volume":"23","author":"Sheu","year":"1991","journal-title":"Cathet Cardiovasc Diagn"},{"key":"R38-12-20210207","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004424-199501000-00004","article-title":"Effects of contrast media on coronary hemodynamics and myocardial metabolism","volume":"30","author":"Sheu","year":"1995","journal-title":"Invest Radiol"},{"key":"R39-12-20210207","first-page":"e148","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina\/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"issue":"Suppl 2","key":"R40-12-20210207","first-page":"S12","article-title":"KDOQI Clinical practice guidelines for diabetes and chronic kidney disease.","volume":"49","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R42-12-20210207","first-page":"79","article-title":"Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy","volume":"58","author":"Benko","year":"2007","journal-title":"Can Assoc Radiol J"},{"key":"R43-12-20210207","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine","volume":"343","author":"Tepel","year":"2000","journal-title":"N Engl J Med"},{"key":"R44-12-20210207","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.ASN.0000116241.47678.49","article-title":"N-Acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials","volume":"15","author":"Kshirsagar","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R45-12-20210207","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(03)00487-X","article-title":"A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study","volume":"41","author":"Baker","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R46-12-20210207","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ehj.2003.11.016","article-title":"Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity","volume":"25","author":"Briguori","year":"2004","journal-title":"Eur Heart J"},{"key":"R47-12-20210207","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcin.2008.11.011","article-title":"N-Acetylcysteine-enhanced contrast provides cardiorenal protection","volume":"2","author":"Meyer","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R48-12-20210207","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1161\/01.CIR.92.10.2855","article-title":"N-Acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects","volume":"92","author":"Arstall","year":"1995","journal-title":"Circulation"},{"key":"R49-12-20210207","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"R50-12-20210207","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"R51-12-20210207","first-page":"932","article-title":"Phase I findings. TIMI Study Group.","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"R52-12-20210207","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/01.CIR.99.15.1945","article-title":"Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group","volume":"99","author":"Gibson","year":"1999","journal-title":"Circulation"},{"key":"R53-12-20210207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.CIR.101.2.125","article-title":"Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs","volume":"101","author":"Gibson","year":"2000","journal-title":"Circulation"},{"key":"R54-12-20210207","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/01.CIR.0000142856.56565.56","article-title":"Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes","volume":"110","author":"Bolognese","year":"2004","journal-title":"Circulation"},{"key":"R55-12-20210207","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.amjcard.2004.01.031","article-title":"Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock","volume":"93","author":"Tarantini","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-201003000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:15:17Z","timestamp":1786371317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-201003000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0b013e32833186a4","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}